REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

EuBiologics Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: EuBiologics Co.,Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a Korea-based company principally engaged in manufacture and distribution of biopharmaceuticals. The Company also engaged in development of biopharmaceuticals and vaccine. The Company was established on March 10, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on January 24, 2017.

Headquarters
8F, Seongdo Bldg., 207, Dosan-Daero, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the EuBiologics Co.,Ltd. report to view the information.

Website: http://www.eubiologics.com

Basic Information
Total Employees:
Purchase the EuBiologics Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the EuBiologics Co.,Ltd. report to view the information.
Registered Capital:
Purchase the EuBiologics Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the EuBiologics Co.,Ltd. report to view the information.
Incorporation Date:
March 10, 2010
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Senior Managing Director
Purchase this report to view the information.
Senior Managing Director
Ownership Details
Purchase this report to view the information.
9.9%
Purchase this report to view the information.
8.4%
Purchase this report to view the information.
6.3%
Company Performance
Financial values in the chart are available after EuBiologics Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.63%▲
Total operating revenue
11.94%▲
Operating profit (EBIT)
-82.26%▼
EBITDA
1.4%▲
Net Profit (Loss) for the Period
N/A
Total assets
1.92%▲
Total equity
-4.39%▼
Operating Profit Margin (ROS)
-2.29%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-1.4%▼
Quick Ratio
-0.2%▼
Cash Ratio
-0.08%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
HL Science Co.,Ltd.
 
L & C Bio Co.,Ltd.
Estec Pharma Co.,Ltd.
 
Geneone Life Science Co.,Ltd.
Seoul Pharma Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo